
Starting with a 2017 bet that stigma was the real barrier to men's healthcare, Dudum built Hims & Hers into a $1.4B-revenue public telehealth company spanning hair loss, sexual health, and GLP-1 weight loss — rewriting how Americans access and purchase prescription care.
Andrew Dudum is the Founder and CEO of Hims & Hers Health, the publicly traded telehealth platform that has transformed how millions of Americans access care for hair loss, sexual wellness, mental health, dermatology, and weight management.
Dudum founded Hims in 2017 with the insight that men were historically reluctant to visit doctors for stigmatized conditions, and that a well-branded direct-to-consumer telehealth platform could expand access. The company went public via SPAC in 2021 and reported 2025 revenue of approximately $2.35 billion, up 59% year over year, with more than 2.5 million subscribers. Hims & Hers's strategic push into GLP-1 weight loss medications has become a major growth driver. Before Hims, Dudum co-founded Atomic, a venture studio that has launched multiple successful companies.

An invitation, extended to Powered readers.